Data coverage, completeness and provenance for PERCHERON THERAPEUTICS LIMITED in the Stock Market API — Health Care · Drug Manufacturers - Specialty & Generic.
Source date: 2026-10-30T04:57:55. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0030 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0035 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/PER/prices · Price parameters and adjustment semantics
Percheron Therapeutics Limited engages in the research and development of antisense pharmaceuticals for cancer and rare diseases in Australia. Its products pipeline includes HMBD-002, a recombinant humanised monoclonal IgG4 antibody, which completed phase I clinical trial to treat to human v-domain immunoglobulin suppressor of T-cell activation (VISTA). The company was formerly known as Antisense Therapeutics Limited and changed its name to Percheron Therapeutics Limited in December 2023. Percheron Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Website: https://percherontx.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/PER/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 24 | yfinance | ||||
| FY2025 (AUD) | 2025-06-30 | 25 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 25 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 26 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/PER
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/PER/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/PER/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/PER/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/PER/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/PER
Free tier — instant API key. Built for AI agents.